On July 11, 2025, Harvard Apparatus Regenerative Technology, Inc. entered into Securities Purchase Agreements with certain investors for a private placement. The investors agreed to purchase an aggregate of 1,250,000 shares of common stock for approximately $2.0 million, at a purchase price of $1.60 per share. The shares were sold without registration under the Securities Act, relying on exemptions for transactions not involving a public offering.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Apparatus Regenerative Technology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-022650), on July 14, 2025, and is solely responsible for the information contained therein.